Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Salus IRB is an AAHRPP-accredited, centralized IRB offering expert and unbiased ethical review of human research protocols, especially clinical trials of drugs, biologics, devices, and behavioral studies. It has a record of rapid turnaround, covering the full spectrum of clinical development (Phase I–IV) and a variety of indications. It is known for consultative support to sponsors and investigators, accelerated review options, and strong expertise in oncology, minimal-risk, multi-site, and SBER (social/behavioral/educational) studies[1][5][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Salus IRB.